IQ-AI Announces Orphan Drug Designation Status

MILWAUKEE, WI / ACCESSWIRE / February 28, 2023 / IQ-AI Limited, (OTCQB:IQAIF)(LSE:IQAI), and its US-based subsidiary, Imaging Biometrics, LLC (Milwaukee, WI) is pleased to announce that the United States Food and Drug Administration (FDA) has …